Lin‐Lin Bu
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Papers in
-
- Head and Neck Cancer Studies 16
- Oncology 29
- Cancer Immunotherapy and Biomarkers 19
- Co-authors
- Zhi‐Jun Sun (44 shared papers)Wen‐Feng Zhang (35 shared papers)Lang Rao (20 shared papers)Wei Liu (16 shared papers)Xingzhong Zhao (15 shared papers)Guang‐Tao Yu (28 shared papers)Shishang Guo (13 shared papers)Bo Cai (8 shared papers)
- Journals
- International Journal of Cancer (6 papers)Advanced Functional Materials (6 papers)Journal of Nanobiotechnology (5 papers)Scientific Reports (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lin‐Lin Bu
127 papers receiving 6.6k citations
Lin‐Lin Bu's Hit Papers
Peers
Comparison fields: 5 of 85
- Biomaterials 1.4k
- Otorhinolaryngology 308
- Oncology 959
- Biomedical Engineering 837
- Physiology 78
Countries citing papers authored by Lin‐Lin Bu
This map shows the geographic impact of Lin‐Lin Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Lin Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Lin Bu more than expected).
Fields of papers citing papers by Lin‐Lin Bu
This network shows the impact of papers produced by Lin‐Lin Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Lin Bu. The network helps show where Lin‐Lin Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Lin Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy Hit paper breakdown → | 2017 | 514 |
| 2 | Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging Hit paper breakdown → | 2016 | 503 |
| 3 | 2015 | 464 | |
| 4 | Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway Hit paper breakdown → | 2022 | 279 |
| 5 | 2017 | 231 | |
| 6 | 2017 | 209 | |
| 7 | 2017 | 197 | |
| 8 | 2019 | 186 | |
| 9 | 2019 | 181 | |
| 10 | 2019 | 180 | |
| 11 | 2018 | 179 | |
| 12 | 2017 | 174 | |
| 13 | 2019 | 169 | |
| 14 | 2021 | 167 | |
| 15 | 2017 | 163 | |
| 16 | 2017 | 147 | |
| 17 | 2016 | 143 | |
| 18 | 2022 | 129 | |
| 19 | 2016 | 108 | |
| 20 | 2019 | 107 |
About Lin‐Lin Bu
Lin‐Lin Bu is a scholar working on Otorhinolaryngology, Oncology, Biomaterials, Biomedical Engineering and Immunology, having authored 139 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Head and Neck Cancer Studies (16 papers), Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (8 papers), Immune cells in cancer (6 papers), Extracellular vesicles in disease (6 papers), Reconstructive Surgery and Microvascular Techniques (6 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). The work is most often cited by research in Biomaterials (1.4k citations), Otorhinolaryngology (308 citations), Oncology (959 citations), Biomedical Engineering (837 citations) and Physiology (78 citations). Lin‐Lin Bu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhi‐Jun Sun, Wen‐Feng Zhang, Lang Rao, Wei Liu, Xingzhong Zhao, Guang‐Tao Yu, Shishang Guo, Bo Cai, Andrew Li and Wei‐Wei Deng. Their work appears in journals such as International Journal of Cancer, Advanced Functional Materials, Journal of Nanobiotechnology, Scientific Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.